182 related articles for article (PubMed ID: 35467086)
1. Does PET scan have any role in the diagnosis of perineural spread associated with the head and neck tumors?
Nie X; Zhou J; Zeng J; Sun J; Chen W; Niu J
Adv Clin Exp Med; 2022 Aug; 31(8):827-835. PubMed ID: 35467086
[TBL] [Abstract][Full Text] [Related]
2. Comparison of diffusion-weighted MR imaging and
Schroeder C; Lee JH; Tetzner U; Seidel S; Kim SY
Eur J Radiol; 2020 Sep; 130():109157. PubMed ID: 32652403
[TBL] [Abstract][Full Text] [Related]
3. Perineural spread in head and neck malignancies: clinical significance and evaluation with 18F-FDG PET/CT.
Paes FM; Singer AD; Checkver AN; Palmquist RA; De La Vega G; Sidani C
Radiographics; 2013 Oct; 33(6):1717-36. PubMed ID: 24108559
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic accuracy of F-18 FDG PET or PET/CT for detection of lymph node metastasis in clinically node negative head and neck cancer patients; A systematic review and meta-analysis.
Kim SJ; Pak K; Kim K
Am J Otolaryngol; 2019; 40(2):297-305. PubMed ID: 30473166
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic and prognostic value of 18F-FDG PET, CT, and MRI in perineural spread of head and neck malignancies.
Dercle L; Hartl D; Rozenblum-Beddok L; Mokrane FZ; Seban RD; Yeh R; Bidault F; Ammari S
Eur Radiol; 2018 Apr; 28(4):1761-1770. PubMed ID: 29086023
[TBL] [Abstract][Full Text] [Related]
6. Response evaluation of cervical lymph nodes after chemoradiation in patients with head and neck cancer - does additional [18F]FDG-PET-CT help?
Dejaco D; Uprimny C; Widmann G; Riedl D; Moser P; Arnold C; Steinbichler TB; Kofler B; Schartinger VH; Virgolini I; Riechelmann H
Cancer Imaging; 2020 Sep; 20(1):69. PubMed ID: 32993805
[TBL] [Abstract][Full Text] [Related]
7. 18F-fluorodeoxyglucose positron emission tomography to evaluate cervical node metastases in patients with head and neck squamous cell carcinoma: a meta-analysis.
Kyzas PA; Evangelou E; Denaxa-Kyza D; Ioannidis JP
J Natl Cancer Inst; 2008 May; 100(10):712-20. PubMed ID: 18477804
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic performance of
Chaput A; Robin P; Podeur F; Ollivier M; Keromnes N; Tissot V; Nonent M; Salaün PY; Rousset J; Abgral R
Laryngoscope; 2018 Feb; 128(2):378-385. PubMed ID: 28600822
[TBL] [Abstract][Full Text] [Related]
9. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
10. Use of Diffusion-Weighted Imaging and
Noij DP; Martens RM; Koopman T; Hoekstra OS; Comans EFI; Zwezerijnen B; de Bree R; de Graaf P; Castelijns JA
Clin Oncol (R Coll Radiol); 2018 Dec; 30(12):780-792. PubMed ID: 30318343
[TBL] [Abstract][Full Text] [Related]
11. Can 3'-Deoxy-3'-((18)F) Fluorothymidine Out Perform 2-Deoxy-2-((18)F) Fluoro-D-Glucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Cervical Lymphadenopathy in Patients With Oral/Head and Neck Cancer?
Schaefferkoetter JD; Carlson ER; Heidel RE
J Oral Maxillofac Surg; 2015 Jul; 73(7):1420-8. PubMed ID: 25869746
[TBL] [Abstract][Full Text] [Related]
12. Comparison of 18F-FDG PET/CT scan and 99mTc-MDP bone scintigraphy in detecting bone metastasis in head and neck tumors.
Al-Bulushi NK; Abouzied ME
Nucl Med Commun; 2016 Jun; 37(6):583-8. PubMed ID: 26813992
[TBL] [Abstract][Full Text] [Related]
13. The impact of multimodality integrated positron emission tomography-computed tomography on improving the staging and management of head and neck malignancy: a cross- sectional study.
Subha ST; Nordin AJ
Sao Paulo Med J; 2022; 140(3):454-462. PubMed ID: 35507996
[TBL] [Abstract][Full Text] [Related]
14. The Diagnostic Value of 18F-FDG PET/CT Scan in Characterizing Adrenal Tumors.
Schaafsma M; Berends AMA; Links TP; Brouwers AH; Kerstens MN
J Clin Endocrinol Metab; 2023 Aug; 108(9):2435-2445. PubMed ID: 36948598
[TBL] [Abstract][Full Text] [Related]
15. FDG-PET delayed imaging for the detection of head and neck cancer recurrence after radio-chemotherapy: comparison with MRI/CT.
Kubota K; Yokoyama J; Yamaguchi K; Ono S; Qureshy A; Itoh M; Fukuda H
Eur J Nucl Med Mol Imaging; 2004 Apr; 31(4):590-5. PubMed ID: 14722678
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic Performance of Response Assessment FDG-PET/CECT in HNSCC Treated With Definitive Radio(chemo)therapy Using NI-RADS.
Paul S; Gupta T; Purandare N; Joshi K; Ghosh-Laskar S; Budrukkar A; Swain M; Sinha S; Kumar A; Joshi A; Prabhash K; Nair S; Rangarajan V; Agarwal JP
Otolaryngol Head Neck Surg; 2023 Oct; 169(4):938-947. PubMed ID: 36856038
[TBL] [Abstract][Full Text] [Related]
17. Role of 18F-Fluorodeoxyglucose Positron Emission Tomography or Positron Emission Tomography/Computed Tomography for the Detection of Recurrent Disease after Treatment of Malignant Melanoma.
Lee JW; Nam SB; Kim SJ
Oncology; 2019; 97(5):286-293. PubMed ID: 31437839
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic value of using 18F-FDG PET and PET/CT in immunocompetent patients with primary central nervous system lymphoma: A systematic review and meta-analysis.
Zou Y; Tong J; Leng H; Jiang J; Pan M; Chen Z
Oncotarget; 2017 Jun; 8(25):41518-41528. PubMed ID: 28514747
[TBL] [Abstract][Full Text] [Related]
19. Is Magnetic Resonance Imaging (MRI) Still a Gold Standard to Detect Breast Cancer: A Meta-analysis.
Su X; Wang S
Curr Med Imaging; 2023; 19(14):1643-1655. PubMed ID: 36748217
[TBL] [Abstract][Full Text] [Related]
20. Initial clinical results of simultaneous 18F-FDG PET/MRI in comparison to 18F-FDG PET/CT in patients with head and neck cancer.
Kubiessa K; Purz S; Gawlitza M; Kühn A; Fuchs J; Steinhoff KG; Boehm A; Sabri O; Kluge R; Kahn T; Stumpp P
Eur J Nucl Med Mol Imaging; 2014 Apr; 41(4):639-48. PubMed ID: 24292211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
